The best bag for work isn’t one-size-fits-all. Sometimes, I need a work bag to do everything at once: look professional but not too stuffy, accommodate gym sneakers and a laptop, and organize ...

The Galaxy S-series phones have always been special in every aspect. Needless to say, these phones look premium and to make them look stand out, Samsung packs the Galaxy S-series phones with ...

However, the asset faced a series of setbacks in 2024. The FDA on Friday approved AstraZeneca and Daiichi Sankyo’s Dato-DXd, to be known as Datroway, for patients with certain advanced breast ...

(RTTNews) - British drug maker AstraZeneca Plc (AZN.L, AZN) and Daiichi Sankyo (DSKYF.PK) announced Monday that their Datroway (datopotamab deruxtecan) has been approved in the United States for ...

A targeted cancer therapy from AstraZeneca’s alliance with Daiichi Sankyo is now FDA approved to treat certain cases of advanced breast cancer, giving the British pharmaceutical giant another ...

The current price of Dai (DAI) is $0.999207, as of February 4, 2025. Over the last 24 hours, the price has moved by -0.11%, with a change of -0.05% in the past hour. For longer-term performance, the ...

Drugmaker Daiichi Sankyo has risen the most in five months after its novel breast cancer treatment won U.S. approval, a milestone in the company’s efforts to turn it into a widely used blockbuster.

Daiichi Sankyo is turning to the German city ... research institute BioMed X to form a new research group to work on targeting solid tumors with multispecific biologics, including antibodies.

German independent biomedical research institute BioMed X has launched a new collaboration with Japanese drugmaker Daiichi Sankyo (TYO: 4568). This collaboration marks the start of a cutting-edge ...

TOKYO & BASKING RIDGE, N.J., January 13, 2025--(BUSINESS WIRE)--Daiichi Sankyo Company, Ltd (TSE: 4568) announced today that it will pay Glycotope $132.5 million to acquire intellectual property ...

Ichi the Witch's first volume sold out in most stores, leading to a reprint by Shueisha. Endorsed by Horikoshi Kohei and Tatsuki Fujimoto, the series is gaining popularity. The manga, written by ...